The Clinical Core of this proposed ADRC will allow us to draw upon our experience in cross-cultural research with Hispanic and non-Hispanic elderly to recruit and to follow for at least five years, 1000 subjects who are cognitively normal, have mild cognitive impairment (MCI) or dementia. Recruitment and longitudinal follow-up of these subjects will meet the needs of the proposed clinical research projects in this ADRC, as well as further other research and developmental projects that will occur during the project period. This Core will make full use of existing community cognitive screening programs, operated by the state-funded memory disorders clinics, as well as the clinics, so as to recruit, comprehensively evaluate and follow up longitudinally subjects who represent the ethnic, language and cultural diversity of Florida. A special focus on recruiting Spanish speaking subjects will be a feature of th is core. Our recruitment strategy will allow normal subjects who are at heightened risk for developing cognitve impairment in the future, as well as MCI and mild dementia subjects to be included. Evaluations will occur at two Clinical Research Centers located at the University of South Florida School of Medicine/ Byrd Institute and the Wien Center, Mount Sinai Medical Center, Miami Beach/University of Miami School of Medicine, Miami. All subjects (i.e., cognitively normal and impaired) who are recruited will be actively encouraged to enroll for autopsy. This core will interact closely with the Data Management, Education and Pathology Cores and with Projects 1 and 2, so as to further the goals of this ADRC. A unique aspect of this Clinical Core is that NIA funds will be supplemented by the State of Florida, administered by the Byrd Institute, allowing such procedures as MRI scans to conducted on all 1000 participants.This will greatly expand both the quality and scope of work that can be performed by the ADRC, which will become a hub to further develop and to support research and collaboration in the areas of early diagnosis and intervention of neurodegenerative diseases as well as the promotion of healthy aging among both Hispanic versus non-Hispanic elders.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG025711-04
Application #
7591634
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
4
Fiscal Year
2008
Total Cost
$657,505
Indirect Cost
Name
University of South Florida
Department
Type
DUNS #
069687242
City
Tampa
State
FL
Country
United States
Zip Code
33612
Kidana, Kiwami; Tatebe, Takuya; Ito, Kaori et al. (2018) Loss of kallikrein-related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice. EMBO Mol Med 10:
Beer, Joanne C; Snitz, Beth E; Chang, Chung-Chou H et al. (2018) Does a cognitive stress test predict progression from mild cognitive impairment to dementia equally well in clinical versus population-based settings? Int Psychogeriatr 30:1435-1445
Burke, Shanna L; Rodriguez, Miriam J; Barker, Warren et al. (2018) Relationship between Cognitive Performance and Measures of Neurodegeneration among Hispanic and White Non-Hispanic Individuals with Normal Cognition, Mild Cognitive Impairment, and Dementia. J Int Neuropsychol Soc 24:176-187
Li, Zeran; Del-Aguila, Jorge L; Dube, Umber et al. (2018) Genetic variants associated with Alzheimer's disease confer different cerebral cortex cell-type population structure. Genome Med 10:43
Sun, Wenyan; Samimi, Hanie; Gamez, Maria et al. (2018) Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies. Nat Neurosci 21:1038-1048
Caneus, Julbert; Granic, Antoneta; Rademakers, Rosa et al. (2018) Mitotic defects lead to neuronal aneuploidy and apoptosis in frontotemporal lobar degeneration caused by MAPT mutations. Mol Biol Cell 29:575-586
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384
Carrasquillo, Minerva M; Allen, Mariet; Burgess, Jeremy D et al. (2017) A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression. Alzheimers Dement 13:663-673
Miller, Jeremy A; Guillozet-Bongaarts, Angela; Gibbons, Laura E et al. (2017) Neuropathological and transcriptomic characteristics of the aged brain. Elife 6:
Caberlotto, Laura; Marchetti, Luca; Lauria, Mario et al. (2016) Integration of transcriptomic and genomic data suggests candidate mechanisms for APOE4-mediated pathogenic action in Alzheimer's disease. Sci Rep 6:32583

Showing the most recent 10 out of 149 publications